Vetnostrum Animal Health Co., Ltd. (TPE:6936)
Taiwan · Delayed Price · Currency is TWD 32.40
+0.20 (0.62%)
Oct 8, 2026, 1:30 PM CST
Vetnostrum Animal Health Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '20 Dec 31, 2020 |
| 2,359 | 2,630 | 2,388 | 2,582 | - | - | |
Market Cap Growth | -7.24% | 10.13% | -7.50% | - | - | - |
Enterprise Value | 1,921 | 2,363 | 2,352 | 2,779 | - | - |
Last Close Price | 32.40 | 34.55 | 32.92 | 34.59 | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '20 Dec 31, 2020 |
PE Ratio | 14.60 | 20.41 | 17.48 | 28.19 | - | - |
PS Ratio | 1.58 | 1.86 | 1.85 | 2.14 | - | - |
PB Ratio | 1.78 | 1.95 | 2.11 | 2.43 | - | - |
P/TBV Ratio | 1.78 | 1.95 | 2.11 | 2.43 | - | - |
P/FCF Ratio | 9.03 | 9.99 | 15.90 | 11.74 | - | - |
P/OCF Ratio | 8.09 | 9.10 | 13.24 | 10.96 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '20 Dec 31, 2020 |
EV/Sales Ratio | 1.29 | 1.67 | 1.82 | 2.30 | - | - |
EV/EBITDA Ratio | 7.26 | 10.83 | 9.93 | 14.76 | - | - |
EV/EBIT Ratio | 9.95 | 15.13 | 13.78 | 24.91 | - | - |
EV/FCF Ratio | 7.36 | 8.97 | 15.66 | 12.63 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '20 Dec 31, 2020 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.07 | 0.19 | 0.32 |
Debt / EBITDA Ratio | 0.08 | 0.11 | 0.10 | 0.41 | 1.00 | 1.48 |
Debt / FCF Ratio | 0.08 | 0.10 | 0.16 | 0.35 | 1.92 | 5.65 |
Net Debt / Equity Ratio | -0.33 | -0.29 | -0.07 | -0.03 | 0.11 | 0.20 |
Net Debt / EBITDA Ratio | -1.73 | -1.79 | -0.35 | -0.14 | 0.55 | 1.00 |
Net Debt / FCF Ratio | -1.68 | -1.48 | -0.55 | -0.12 | 1.06 | 3.66 |
Asset Turnover | 0.87 | 0.91 | 0.92 | 0.85 | - | 0.79 |
Inventory Turnover | 2.48 | 2.68 | 2.32 | 2.46 | - | 3.07 |
Quick Ratio | 1.70 | 2.24 | 1.22 | 1.05 | 0.80 | 0.93 |
Current Ratio | 2.62 | 3.36 | 2.62 | 2.19 | 1.74 | 1.75 |
Return on Equity (ROE) | 12.44% | 10.38% | 12.46% | 8.67% | - | 11.32% |
Return on Assets (ROA) | 7.04% | 6.28% | 7.57% | 4.89% | - | 5.99% |
Return on Invested Capital (ROIC) | 16.90% | 12.56% | 13.20% | 8.23% | 8.90% | 9.86% |
Return on Capital Employed (ROCE) | 14.40% | 11.40% | 14.90% | 10.40% | 11.70% | 12.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '20 Dec 31, 2020 |
Earnings Yield | 6.85% | 4.90% | 5.72% | 3.55% | - | - |
FCF Yield | 11.07% | 10.01% | 6.29% | 8.52% | - | - |
Dividend Yield | 4.66% | 4.37% | 5.12% | 3.01% | - | - |
Payout Ratio | 75.93% | 95.25% | 50.46% | 87.46% | 77.45% | 78.50% |
Buyback Yield / Dilution | -7.89% | -6.69% | -0.09% | -4.69% | -15.28% | - |
Total Shareholder Return | -3.23% | -2.32% | 5.04% | -1.68% | -15.28% | - |